Cargando…

ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology

BACKGROUND: Cytologically indeterminate thyroid nodules currently present a challenge for clinical decision-making. The main aim of our study was to determine whether the classifications, American College of Radiology (ACR) TI-RADS and 2015 American Thyroid Association (ATA) guidelines, in associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbosa, Thayse Lozovoy Madsen, Junior, Cleo Otaviano Mesa, Graf, Hans, Cavalvanti, Teresa, Trippia, Marcus Adriano, da Silveira Ugino, Ricardo Torres, de Oliveira, Gabriel Lucca, Granella, Victor Hugo, de Carvalho, Gisah Amaral
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819341/ https://www.ncbi.nlm.nih.gov/pubmed/31664992 http://dx.doi.org/10.1186/s12902-019-0429-5

Ejemplares similares

OR27-2 Inter-reader Agreement of ATA Sonographic Risk In Thyroid Nodules With Indeterminate Cytology
por: Linares, Maria, et al.
Publicado: (2019)

The diagnostic efficacy and inappropriate biopsy rate of ACR TI-RADS and ATA guidelines for thyroid nodules in children and adolescents
por: Li, Guanghan, et al.
Publicado: (2023)

Validation of TIRADS ACR Risk Assessment of Thyroid Nodules in Comparison to the ATA Guidelines
por: Merhav, Goni, et al.
Publicado: (2021)

Prevalence of hyperfunctioning thyroid nodules among those in need of fine needle aspiration cytology according to ATA 2015, EU-TIRADS, and ACR-TIRADS
por: Noto, Benjamin, et al.
Publicado: (2020)

Comparison of the C-TIRADS, ACR-TIRADS, and ATA guidelines in malignancy risk stratification of thyroid nodules
por: Cai, Yifeng, et al.
Publicado: (2023)

Diagnostic Performance of ACR TI-RADS and ATA Guidelines in the Prediction of Thyroid Malignancy: A Prospective Single Tertiary Center Study and Literature Review
por: Torshizian, Ashkan, et al.
Publicado: (2023)

The Diagnostic Efficacy of the American College of Radiology (ACR) Thyroid Imaging Report and Data System (TI-RADS) and the American Thyroid Association (ATA) Risk Stratification Systems for Thyroid Nodules
por: Chen, Fei, et al.
Publicado: (2022)

MON-LB86 The Sensitivity and Specificity of Various Thyroid Nodule Ultrasound Characteristics and the Diagnostic Accuracy of the ATA Guidelines and ACR TI-RADS for Predicting Thyroid Cancer at an Urban Endocrinology Clinic
por: Dacuycuy, Leonierose, et al.
Publicado: (2020)

MON-525 ATA and ACR TIRADS Classification Systems as Additional Predictors of Malignancy in Afirma GSC Suspicious Thyroid Nodules
por: Azaryan, Irina, et al.
Publicado: (2020)

Cytologically indeterminate thyroid nodules: increased diagnostic performance with combination of US TI-RADS and a new scoring system
por: He, Ya-Ping, et al.
Publicado: (2017)

Q-Elastography in the Presurgical Diagnosis of Thyroid Nodules with Indeterminate Cytology
por: Cantisani, Vito, et al.
Publicado: (2012)

Using ultrasonographic features to predict the outcomes of patients with small papillary thyroid carcinomas: a retrospective study implementing the 2015 ATA patterns and ACR TI-RADS categories
por: Park, Hee Min, et al.
Publicado: (2022)

Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
por: Vignali, Paola, et al.
Publicado: (2023)

Diagnostic value of ACR TI-RADS combined with three-dimensional shear wave elastography in ACR TI-RADS 4 and 5 thyroid nodules
por: Hao, Lijun, et al.
Publicado: (2023)

Tips for improving consistency of thyroid nodule interpretation with ACR TI-RADS
por: Low, Gavin, et al.
Publicado: (2022)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

The 2017 ACR TI-RADS: pictorial essay
por: Pires, André Tojal, et al.
Publicado: (2022)

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
por: Dharampal, Navjit, et al.
Publicado: (2022)

Diagnostic performance of simplified TI-RADS for malignant thyroid nodules: comparison with 2017 ACR-TI-RADS and 2020 C-TI-RADS
por: Chen, Zhiguang, et al.
Publicado: (2022)

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy
por: Súss, Shirlei Kugler Aiçar, et al.
Publicado: (2018)

ATA Announcement
por: Forstag, Benjamin
Publicado: (2011)

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate
por: Wu, Dandan, et al.
Publicado: (2020)

Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification
por: Zhou, Yuanyuan, et al.
Publicado: (2023)

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2022)

THU619 Atypical Clinical Presentation Of Adrenal Hemorrhage
por: Madsen-Barbosa, Thayse Lozovoy, et al.
Publicado: (2023)

ThyroidPrint®: clinical utility for indeterminate thyroid cytology
por: Olmos, Roberto, et al.
Publicado: (2023)

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021)

Deep Learning Based on ACR TI-RADS Can Improve the Differential Diagnosis of Thyroid Nodules
por: Wu, Ge-Ge, et al.
Publicado: (2021)

Ultrasound Radiomics Nomogram to Diagnose Sub-Centimeter Thyroid Nodules Based on ACR TI-RADS
por: Lu, Wenwu, et al.
Publicado: (2022)

Concordance of the ACR TI-RADS Classification With Bethesda Scoring and Histopathology Risk Stratification of Thyroid Nodules
por: Huang, Elaine Y. F., et al.
Publicado: (2023)

The ATA guidelines of thyrotoxicosis
por: Junik, Roman
Publicado: (2013)

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
por: Rowe, Leslie R, et al.
Publicado: (2006)

Evaluation and Management of Indeterminate Thyroid Nodules: The Revolution of Risk Stratification Beyond Cytological Diagnosis
por: Valderrabano, Pablo, et al.
Publicado: (2017)

The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology
por: Sencar, Muhammed Erkam, et al.
Publicado: (2022)

An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules
por: Taccogna, Silvia, et al.
Publicado: (2022)

Are the anatomical, clinical, and ultrasound characteristics of thyroid nodules with Bethesda III or IV cytology and ACR TI-RADS 3, 4, or 5 able to refine the indications for molecular diagnostic tests?
por: Penna, Gustavo Cancela e, et al.
Publicado: (2021)

Diagnostic performance of the EU TI‐RADS and ACR TI‐RADS scoring systems in predicting thyroid malignancy
por: Chatti, Hiba‐Allah, et al.
Publicado: (2023)

Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology
por: Sciacchitano, Salvatore, et al.
Publicado: (2017)

Reliability of Thyroid Imaging Reporting and Data System (TI-RADS), and ultrasonographic classification of the American Thyroid Association (ATA) in differentiating benign from malignant thyroid nodules
por: de Macedo, Bruno Mussoi, et al.
Publicado: (2018)

Genetic testing for indeterminate thyroid cytology: review and meta-analysis
por: Vargas-Salas, Sergio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f5b94ih31sir613a42v9ou9jgm